Epigral Ltd

MFL03 Dec 2024

Chemicals

₹

+31.60 (+1.53%)

Lowest Today

Highest Today

Prev. Close

Today’s Open

52 Week High

52 Week Low

BUY

SELL

To Invest in Epigral Ltd

Epigral Ltd

Chemicals

MFL03 Dec 2024

₹

+31.60 (+1.53%)

OverviewFundamentals

Corporate action

Peer comparison

Cash flow

Corporate Action

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

All

Dividends

Bonus

Splits

Others

Ex-Date	Type	Description	Record Date
22-Apr-2024	D	Outcome of Board Meeting held on Monday, 22nd April, 2024 Recommended final dividend of Rs. 5.00(50.00%) per equity share on 4,15,50,158 Equity Shares of Rs. 10/- each for the financial year ended 31st March, 2024, subject to approval of the Shareholders of the Company at the forthcoming Annual General Meeting. The Book Closure and Record Date for this purpose will be intimated in due course.	02-Jul-2024
25-Apr-2023	D	Meghmani Finechem Limited informs that the Board of Directors at its meeting held today i.e. Tuesday, 25th April, 2023 has inter-alia transacted the following business: Recommended final dividend of Rs. 2.50 (25%) per equity share on 4,15,50,158 Equity Shares of Rs. 10/- each for the financial year ended 31st March, 2023, subject to approval of the Shareholders of the Company at the forthcoming Annual General Meeting. Meghmani Finechem Limited submits the Intimation of Record Date for Dividend. (As Per BSE Announcement Dated on 03/06/2023)	20-Jun-2023
19-Jan-2023	D	The Board of Directors of the Company at its meeting held today i.e. on 19th January, 2023 has also declared Interim Dividend at Rs. 2.50/- (i.e. 25%) per Equity Share on 4,15,50,158 Equity Shares of Rs. 10/- each for the year FY 2022-23. Meghmani Finechem Limited informs that the Board of Directors of the Company at its meeting held today i.e. on 19th January, 2023 has also declared Interim Dividend at Rs. 2.50/- (i.e. 25%) per Equity Share on 4,15,50,158 Equity Shares of Rs. 10/- each for the year FY 2022-23.	01-Feb-2023
29-Oct-2024	BC	Quarterly Results Outcome of Board Meeting held on Saturday, 9th November, 2024 and submission of Un-Audited Financial Results (Standalone & Consolidated) for the Second Quarter and Half Year end	09-Nov-2024
28-Oct-2024	BC	Trading members of the Exchange are hereby informed that the under mentioned securities of Epigral Limited (Scrip Code :543332, ISIN No. INE071N01016) are listed and admitted for trading on the Exch	29-Oct-2024
17-Aug-2024	BC	Epigral Limited submits the Postal Ballot Notice. Epigral Limited submits the Scrutinizer''s Report and voting result of the Postal Ballot. (As per BSE Announcement Dated on 17/09/2024)	16-Sep-2024
09-Aug-2024	BC	Epigral Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/08/2024 inter alia to consider and approve inter alia proposal for raising of funds through is	14-Aug-2024
16-Jul-2024	BC	Epigral Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 24/07/2024 inter alia to consider and approve Un-audited Financial Results for Quarter ended 30th	24-Jul-2024

No Rights has been declared by MFL

Book Closure

Record Date	Split Date	Purpose
09-Nov-2024	-	Quarterly Results Outcome of Board Meeting held on Saturday, 9th November, 2024 and submission of Un-Audited Financial Results (Standalone & Consolidated) for the Second Quarter and Half Year end
29-Oct-2024	-	Trading members of the Exchange are hereby informed that the under mentioned securities of Epigral Limited (Scrip Code :543332, ISIN No. INE071N01016) are listed and admitted for trading on the Exch
16-Sep-2024	01 Jan'1900	Epigral Limited submits the Postal Ballot Notice. Epigral Limited submits the Scrutinizer''s Report and voting result of the Postal Ballot. (As per BSE Announcement Dated on 17/09/2024)
14-Aug-2024	-	Epigral Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/08/2024 inter alia to consider and approve inter alia proposal for raising of funds through is
24-Jul-2024	-	Epigral Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 24/07/2024 inter alia to consider and approve Un-audited Financial Results for Quarter ended 30th

Peer Comparison

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

Scrip Name	Price	Daily Change	M.Cap (Cr)	1 Year Returns %	P/E (TTM)	PB Ratio
Epigral Ltd ₹2,095.90(+31.60/1.53%)	2,095.90	+31.60	9,041.99	131.28	30.91	5.22
BASF India Ltd ₹5,670.65(+10.20/0.18%)	5,670.65	+10.20	24,545.77	90.95	38.35	7.00
DIC India Ltd ₹679.75(-15.25/-2.19%)	679.75	-15.25	623.94	54.10	56.93	1.54
Bhagawati Oxygen Ltd ₹53.39(+0.04/0.07%)	53.39	+0.04	12.33	41.81	0.00	3.00
Oriental Aromatics Ltd ₹458.40(-4.75/-1.03%)	458.40	-4.75	1,542.68	31.67	37.76	2.34
Atul Ltd ₹7,395.05(+35.80/0.49%)	7,395.05	+35.80	21,772.33	9.69	51.52	3.91

Cash Flow

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

PARTICULARS	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020
Cash and Cash Equivalents at Beginning of the year	14.19	25.04	0.68	0.10	129.21
Net Cash from Operating Activities	397.69	626.16	283.82	229.22	164.68
Net Cash Used In Investing Activities	-401.10	-437.22	-454.68	-196.73	-363.21
Net Cash Used In Financing Activities	-7.60	-199.79	195.22	-31.90	69.41
Net Inc./Dec In Cash And Cash Equivalents	-11.01	-10.85	24.36	0.58	-129.12
Cash And Cash Equivalents At End Of The Year	3.18	14.19	25.04	0.68	0.10

Share Holding

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

Promoter Shareholding

68.94%

FII Shareholding

3.02%

DII Shareholding

3.83%

Public Shareholding

24.20%

**Promoter pledged shareholding 68.94%

About Epigral Ltd

Epigral Ltd is in the Chemicals sector, having a market capitalization of Rs. 9041.99 crores. It has reported a sales of Rs. 626.06 crores and a net profit of Rs. 80.53 crores for the quarter ended December 2018. The company management includes Maulik Jayantibhai Patel, Maulik Jayantibhai Patel,Kaushal Ashishbhai Soparkar,Karana Rameshbhai Patel,Ankit Natwarlal Patel,Darshan Anandbhai Patel,Manubhai Khodidas Patel,NIRALI BHAVIN PARIKH,Sanjay K Asher,Kanubhai S Patel,Raju Swamy,Gaurang Trivedi. (Epigral Ltd) among others.

Chairman

Maulik Jayantibhai Patel

Registered office

CH/1 CH/2 GIDC Indl Estate,Dahej Tal Vagra,Bharuch,Gujarat,392130

FAX :91-79-29709605

Background

Incorporation Year2007

Face Value₹10

Market Lot1